The testis in immune privilege
Abstract
Summary: The production, differentiation, and presence of male gametes represent inimitable challenges to the immune system, as they are unique to the body and appear long after the maturation of the immune system and formation of systemic self‐tolerance. Known to protect germ cells and foreign tissue grafts from autoimmune attack, the ‘immune privilege’ of the testis was originally, and somewhat simplistically, attributed to the existence of the blood–testis barrier. Recent research has shown a previously unknown level of complexity with a multitude of factors, both physical and immunological, necessary for the establishment and maintenance of the immunotolerance in the testis. Besides the blood–testis barrier and a diminished capability of the large testicular resident macrophage population to mount an inflammatory response, it is the constitutive expression of anti‐inflammatory cytokines in the testis by immune and particularly somatic cells, that represents an essential element for local immunosuppression. The role of androgens in testicular immune regulation has long been underestimated; yet, accumulating evidence now shows that they orchestrate the inhibition of proinflammatory cytokine expression and shift cytokine balance toward a tolerogenic environment. Furthermore, the role of the testicular dendritic cells in suppressing antigen‐specific immunity and T‐lymphocyte activation is discussed. Finally, the active role mast cells play in the induction and amplification of immune responses, both in infertile humans and in experimental models, highlights the importance of preventing mast cell activation to maintain the immune‐privileged status of the testis.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Testicular tissue is characterized as an immune-privileged site.
“Testicular tissue is characterized as an immune-privileged site.”
From The Immune Landscape and Immunotherapeutic Strategies in Platinum-Refractory Testicular Germ Cell Tumors (2024) · cites this paper as [15]
Cites
BIZZARRO, A., VALENTINI, G., MARTINO, G. D., DAPONTE, A., DE BELLIS, A., & IACONO, G. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-32 · Cited by 186 · see citing works
Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., Capello, E., Mancardi, G. L., & Aloisi, F. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/65.2.124 · Cited by 176 · see citing works
Suter, T., Biollaz, G., Gatto, D., Bernasconi, L., Herren, T., Reith, W., & Fontana, A. (2003) · European Journal of Immunology · doi:10.1002/eji.200323611 · Cited by 114 · see citing works
Androgens Modulate Interleukin‐6 Production by Gingival Fibroblasts In Vitro
Gornstein, R. A., Lapp, C. A., Bustos‐Valdes, S. M., & Zamorano, P. (1999) · Journal of Periodontology · doi:10.1902/jop.1999.70.6.604 · Cited by 87 · see citing works
Zitzmann, M., Erren, M., Kamischke, A., Simoni, M., & Nieschlag, E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0847 · Cited by 49 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Hasegawa, H., Mizoguchi, I., Chiba, Y., Ohashi, M., Xu, M., & Yoshimoto, T. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00479 · Cited by 142 · see citing works
Specific Immune Cell and Cytokine Characteristics of Human Testicular Germ Cell Neoplasia
Klein, B., Haggeney, T., Fietz, D., Indumathy, S., Loveland, K. L., Hedger, M., Kliesch, S., Weidner, W., Bergmann, M., & Schuppe, H.-C. (2016) · Human Reproduction · doi:10.1093/humrep/dew211 · Cited by 114 · see citing works
Evolution of Cancer Vaccines—Challenges, Achievements, and Future Directions
Tay, B. Q., Wright, Q., Ladwa, R., Perry, C., Leggatt, G., Simpson, F., Wells, J. W., Panizza, B. J., Frazer, I. H., & Cruz, J. L. G. (2021) · Vaccines · doi:10.3390/vaccines9050535 · Cited by 76 · see citing works
Evmorfopoulos, K., Marsitopoulos, K., Karachalios, R., Karathanasis, A., Dimitropoulos, K., Tzortzis, V., Zachos, I., & Vlachostergios, P. J. (2024) · Cancers · doi:10.3390/cancers16020428 · Cited by 11 · see citing works
“However, this immune suppression has to be in balance with the activation of the immune response that aims to fight infection, trauma, cancer and conditions resulting in tissue damage [15].”
Background
- Authors
- Fijak, M., & Meinhardt, A.
- Affiliations
- Justus-Liebig-Universität Gießen (DE)
- Corresponding author
- Meinhardt, Andreas
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2006-09-14
- Volume
- 213
- Issue
- 1
- Pages
- 66-81
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W1991594550
- Cited by
- 483
- References
- 5
- Citations by year
- 2026: 30 · 2025: 27 · 2024: 41 · 2023: 30 · 2022: 36 · 2021: 37 · 2020: 26 · 2019: 15 · 2018: 26 · 2017: 15 · 2016: 22 · 2015: 21 · 2014: 23 · 2013: 22 · 2012: 19
- FWCI
- 1.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Immunological Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Keywords
- testis, immune privilege, blood-testis barrier, anti-inflammatory cytokines, testicular macrophages, androgens, mast cells, T cell activation, infertility, local immunosuppression
- MeSH terms
- Animals, Humans, Immune Tolerance, Male, Testis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review